Oakworth Capital Inc. Purchases 1,400 Shares of Colgate-Palmolive (NYSE:CL)

Oakworth Capital Inc. raised its position in Colgate-Palmolive (NYSE:CL) by 90.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,955 shares of the company’s stock after buying an additional 1,400 shares during the quarter. Oakworth Capital Inc.’s holdings in Colgate-Palmolive were worth $236,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. TRUE Private Wealth Advisors raised its position in Colgate-Palmolive by 59.3% during the fourth quarter. TRUE Private Wealth Advisors now owns 4,939 shares of the company’s stock valued at $394,000 after purchasing an additional 1,839 shares in the last quarter. Tyche Wealth Partners LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter valued at $745,000. Everence Capital Management Inc. raised its holdings in shares of Colgate-Palmolive by 32.6% during the 4th quarter. Everence Capital Management Inc. now owns 19,597 shares of the company’s stock worth $1,562,000 after buying an additional 4,820 shares in the last quarter. Wealth Alliance acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth $313,000. Finally, DGS Capital Management LLC acquired a new stake in Colgate-Palmolive in the fourth quarter valued at about $209,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Up 0.7 %

Shares of NYSE CL opened at $86.77 on Thursday. The company’s 50 day moving average price is $86.97 and its 200-day moving average price is $80.63. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. Colgate-Palmolive has a 52-week low of $67.62 and a 52-week high of $90.37. The company has a market capitalization of $71.32 billion, a P/E ratio of 31.21, a price-to-earnings-growth ratio of 3.24 and a beta of 0.42.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 26th. The company reported $0.87 earnings per share for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. The business had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.89 billion. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. Colgate-Palmolive’s quarterly revenue was up 6.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.77 earnings per share. Equities analysts forecast that Colgate-Palmolive will post 3.49 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.30%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s payout ratio is currently 69.06%.

Insider Buying and Selling

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 29,772 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $84.06, for a total value of $2,502,634.32. Following the transaction, the chief executive officer now directly owns 301,343 shares of the company’s stock, valued at $25,330,892.58. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 29,772 shares of the firm’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $84.06, for a total value of $2,502,634.32. Following the completion of the sale, the chief executive officer now directly owns 301,343 shares in the company, valued at $25,330,892.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The disclosure for this sale can be found here. Insiders sold 232,371 shares of company stock valued at $19,505,099 over the last 90 days. Company insiders own 0.34% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. Morgan Stanley boosted their target price on Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research note on Monday, January 29th. Stifel Nicolaus increased their price objective on shares of Colgate-Palmolive from $89.00 to $94.00 and gave the company a “buy” rating in a research note on Wednesday, April 10th. Wells Fargo & Company boosted their target price on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a research note on Monday, January 29th. Evercore ISI increased their price target on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a research note on Monday, April 8th. Finally, UBS Group boosted their price objective on Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, January 29th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $89.50.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.